PSMA-11

05/25/2023 - "Imaging quality of an artificial intelligence denoising algorithm: validation in 68Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancer."
01/01/2023 - "Unspecific 18F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer."
03/31/2021 - "68Ga PSMA-11 PET/CT scans of patients with de novo or suspected recurrent prostate cancer were retrospectively reformatted using both the OSEM and BSREM algorithms. "
01/01/2021 - "FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging."
12/01/2020 - "Therefore, combined with the patient's PSA, MRI and 68Ga PSMA-11 PET/CT, our clinical diagnosis was prostate cancer. "

01/01/2021 - "Biodistribution studies at 1 h post-administration revealed that [177Lu]-PSMA-617 uptake in PC3-PIP tumors was 21.71 ± 6.13, 18.7 ± 2.03, 26.44 ± 2.94, 16.21 ± 3.5, 13.52 ± 3.68, and 12.03 ± 1.96 %ID/g when 0, 5, 100, 500, 1000, and 2000 pmoles of PSMA-11 were added, respectively. "
01/01/2021 - "Groups of athymic nude mice (n = 4) bearing PC3-PIP (PSMA+) tumor xenografts were administered with [177Lu]-PSMA-617 along with 0, 5, 100, 500, 1000, and 2000 pmoles of PSMA-11 and biodistribution studies were performed at 1 h. "
01/01/2016 - "In two large diagnostic studies (n = 319 and n = 248) PET/CT with PSMA-11 successfully localized the recurrent tumor in approximately 90% of patients with biochemical relapse. "
10/01/2021 - "The specific tumor uptake of this compound (7.59 ± 0.95 %ID/g, 1 h after injection) was detected to be significantly higher than that of the parental tracer PSMA-11. "
01/01/2021 - "The uptake of [177Lu]-PSMA-617 in the salivary gland and kidney can be substantially reduced without significantly impacting tumor uptake by adding cold PSMA-11."

09/01/2019 - "PSMA-11 PET/CT(MRI) has a very good performance for the identification of LN metastases in patients with BCR after RP. "
09/01/2019 - "Regional and template-based correlations between the presence of LN metastases on histopathology and whole-body PSMA-11 PET/CT(MRI) results were evaluated. "
01/01/2022 - "Prostate cancer cardiac metastasis detected on serial imaging with [68Ga] PSMA-11 PET/CT."
01/01/2021 - "Urachal remnant metastasis detected on [68Ga] PSMA-11 PET/CT in an asymptomatic prostate cancer patient with biochemical recurrence."
01/01/2019 - "Gallium-68-labeled PSMA-11 PET is sensitive for prostate cancer metastases in patients with biochemically recurrent prostate cancer. "

10/19/2022 - "Mild 68Ga PSMA-11 Uptake in Incidental Pituitary Adenoma."

01/01/2017 - "Among the five cases evaluated for lesion characterization glioma and atypical meningioma patients showed higher SUVmax in the lesion with Ga PSMA-11 than with F-FDG and converse in cases of lymphoma. "